Skip to main content
Keeps Biopharma Inc. logo

Keeps Biopharma Inc. — Investor Relations & Filings

Ticker · 256940 ISIN · KR7256940008 KO Manufacturing
Open in API
Filings indexed 290 across all filing types
Latest filing 2024-03-22 Proxy Solicitation & In…
Country KR South Korea
Listing KO 256940

About Keeps Biopharma Inc.

http://kpscorp.co.kr/

Keeps Biopharma Inc. is a company with operations in both manufacturing and biopharmaceuticals. Its manufacturing activities include the production of equipment for semiconductors and flat panel displays, such as organic light-emitting diodes (OLEDs), as well as cleanroom consumables. Concurrently, the company is expanding its biopharmaceutical business through research and development. Its strategic focus is on building a therapeutic pipeline centered on oncology and metabolic diseases, which includes the development of novel anticancer drugs and combination therapies.

Recent filings

Filing Released Lang Actions
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Proxy Solicitation Reference Document) and is a correction filing ('정정신고') related to the company's proxy materials for an upcoming general meeting. It contains detailed financial statements (consolidated and separate) as part of the disclosure requirements for shareholders to make informed voting decisions. This falls under the category of Proxy Solicitation & Information Statement.
2024-03-22 Korean
사업보고서 (2023.12)
Audit Report / Information Classification · 100% confidence The document is a comprehensive 'Independent Auditor's Report' (감사보고서) for KPS Co., Ltd. for the fiscal year ending December 31, 2023. It includes the auditor's opinion, key audit matters, and the full set of consolidated financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, and Statement of Cash Flows) along with detailed notes. Since this is a standalone audit report containing the full financial statements and audit opinion, it is classified as an Audit Report (AR). FY 2023
2024-03-21 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal regulatory filing titled 'Audit Report Submission' (감사보고서 제출) from a Korean company (KPS). It provides a summary of the audit opinion, key financial data (assets, liabilities, revenue, profit/loss), and capital structure details as required by the Korea Exchange (KRX) disclosure system. While it contains financial data, it is a standardized regulatory announcement summarizing the audit results rather than the full annual report (10-K) or a standalone audit report (AR). In the context of Korean regulatory filings, this is a specific disclosure type for the submission of the audit report. FY 2023
2024-03-21 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by KPS. It outlines the date, location, and agenda items (such as financial statement approval, director/auditor appointments, and remuneration limits) for the upcoming meeting. This type of document is a standard proxy solicitation or notice of meeting sent to shareholders to inform them of the upcoming vote, which falls under the Proxy Solicitation & Information Statement category.
2024-03-14 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (KPS) announcing a significant change in revenue or profit structure (30% or more). This is a standard disclosure requirement in the Korean stock market (DART system) for preliminary earnings results. Since it provides key financial highlights (revenue, operating profit, net income) and explains the reasons for the change, it fits the definition of an Earnings Release (ER). FY 2023
2024-03-14 Korean
주주총회집중일개최사유신고
AGM Information Classification · 98% confidence The document is a formal regulatory filing submitted by KPS regarding the scheduling of their Annual General Meeting (AGM) on a 'concentrated date' (a date when many companies hold their AGMs). It explains the reasons for choosing this date, such as audit report timelines. Since it is a regulatory notification regarding meeting logistics rather than the meeting materials themselves, the proxy statement, or the voting results, it falls under the general regulatory filing category.
2024-03-14 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.